Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Drug and therapeutics committees in Danish hospitals: a survey of organization, activities and drug selection procedures.

Plet HT, Hallas J, Nielsen GS, Kjeldsen LJ.

Basic Clin Pharmacol Toxicol. 2013 Apr;112(4):264-9. doi: 10.1111/bcpt.12028. Epub 2012 Dec 20.

2.

Literature review on the structure and operation of Pharmacy and Therapeutics Committees.

Durán-García E, Santos-Ramos B, Puigventos-Latorre F, Ortega A.

Int J Clin Pharm. 2011 Jun;33(3):475-83. doi: 10.1007/s11096-011-9501-6. Epub 2011 Mar 18. Review.

PMID:
21416393
3.

Drug and Therapeutics (D & T) committees in Dutch hospitals: a nation-wide survey of structure, activities, and drug selection procedures.

Fijn R, Brouwers JR, Knaap RJ, De Jong-Van Den Berg LT.

Br J Clin Pharmacol. 1999 Aug;48(2):239-46.

4.

Structure and activities of hospital drug committees in Germany.

Thürmann PA, Harder S, Steioff A.

Eur J Clin Pharmacol. 1997;52(6):429-35.

PMID:
9342577
5.

Drug and therapeutics committees: the relationships among structure, function, and effectiveness.

Plumridge RJ, Stoelwinder JU, Rucker TD.

Hosp Pharm. 1993 Jun;28(6):492-3, 496-8, 508.

PMID:
10126453
6.

Activities, functions, and structure of pharmacy and therapeutics committees in large teaching hospitals.

Mannebach MA, Ascione FJ, Gaither CA, Bagozzi RP, Cohen IA, Ryan ML.

Am J Health Syst Pharm. 1999 Apr 1;56(7):622-8.

PMID:
10423208
7.

Drug and Therapeutics Committees in Australia: expected and actual performance.

Weekes LM, Brooks C.

Br J Clin Pharmacol. 1996 Nov;42(5):551-7.

8.

Dutch hospital drug formularies: pharmacotherapeutic variation and conservatism, but concurrence with national pharmacotherapeutic guidelines.

Fijn R, Engels SA, Brouwers JR, Knaap RJ, De Jong-Van den Berg LT.

Br J Clin Pharmacol. 2000 Mar;49(3):254-63.

9.

Perspectives on Drug and Therapeutics Committee policy implementation.

Tan EL, Day RO, Brien JA.

Res Social Adm Pharm. 2005 Dec;1(4):526-45.

PMID:
17138494
10.

A survey of drug and therapeutics committees operating in Ireland.

Ferrando MC, Henman MC.

J Clin Hosp Pharm. 1986 Apr;11(2):131-40.

PMID:
3711361
11.

Structure and procedures of the pharmacy and therapeutic committees in Spanish hospitals.

Puigventós F, Santos-Ramos B, Ortega A, Durán-García E.

Pharm World Sci. 2010 Dec;32(6):767-75. doi: 10.1007/s11096-010-9435-4. Epub 2010 Sep 7.

PMID:
20820918
12.

Establishing and strengthening a medicine and therapeutics committee in a medical college in Nepal: initial experiences.

Shankar PR, Humagain B, Piryani RM, Jha N, Osti B.

Pharm World Sci. 2009 Apr;31(2):241-5. doi: 10.1007/s11096-008-9263-y. Epub 2008 Dec 5.

PMID:
19058026
13.

The right drug, but from whose perspective? A framework for analysing the structure and activities of drug and therapeutics committees.

Hoffmann M.

Eur J Clin Pharmacol. 2013 May;69 Suppl 1:79-87. doi: 10.1007/s00228-013-1491-y. Epub 2013 May 3.

14.

A survey of selective administration procedures in formulary maintenance.

Quigley MA, Brown WM.

Hosp Pharm. 1981 Jul;15(7):371-4, 378-80.

PMID:
10252001
15.

A survey of Pharmacy and Therapeutic committees across Canada: scope and responsibilities.

Mittmann N, Knowles S.

Can J Clin Pharmacol. 2009 Winter;16(1):e171-7. Epub 2009 Feb 25.

PMID:
19242000
17.

Organization and operation of P & T Committees in the state of Florida: a survey.

Hatton RC, Doering PL.

Hosp Formul. 1990 Sep;25(9):983-6, 988-9.

PMID:
10106259
18.

Adherence to hospital drug formularies and cost of drugs in hospitals in Denmark.

Plet HT, Hallas J, Kjeldsen LJ.

Eur J Clin Pharmacol. 2013 Oct;69(10):1837-43. doi: 10.1007/s00228-013-1540-6. Epub 2013 Jun 14.

PMID:
23765410
19.

Prioritising drug and therapeutics committee (DTC) decisions: a national survey.

Tan EL, Day RO, Brien JA.

Pharm World Sci. 2007 Apr;29(2):90-6. Epub 2006 Dec 23.

PMID:
17187221
20.

Effective decision-making in a changing healthcare environment: a P & T Committee interview.

Zoloth A, Yon JL, Woolf R.

Hosp Formul. 1989 Feb;24(2):85-7, 90, 93 passim.

PMID:
10291815

Supplemental Content

Support Center